MX356601B - Pharmaceutical combination with anti-migraine effect, in solid presentation of extended release. - Google Patents

Pharmaceutical combination with anti-migraine effect, in solid presentation of extended release.

Info

Publication number
MX356601B
MX356601B MX2010003532A MX2010003532A MX356601B MX 356601 B MX356601 B MX 356601B MX 2010003532 A MX2010003532 A MX 2010003532A MX 2010003532 A MX2010003532 A MX 2010003532A MX 356601 B MX356601 B MX 356601B
Authority
MX
Mexico
Prior art keywords
pharmaceutical combination
migraine
extended release
release
extended
Prior art date
Application number
MX2010003532A
Other languages
Spanish (es)
Other versions
MX2010003532A (en
Inventor
Maldonado Pérez Alejandro
Romero Medina Silvia
Del Carmen Sanchez Flores Maria
Original Assignee
Productos Maver S A De C V
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Productos Maver S A De C V filed Critical Productos Maver S A De C V
Priority to MX2010003532A priority Critical patent/MX356601B/en
Publication of MX2010003532A publication Critical patent/MX2010003532A/en
Publication of MX356601B publication Critical patent/MX356601B/en

Links

Landscapes

  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The present invention refers to a pharmaceutical combination in solid form orally administered, which is of long lasting release for attacking the signs and symptoms of migraine in its different stages, also including an immediate release matrix mainly formed by sumatripan and metoclopramide and extended release pellets containing ketorolako. The main actives contained in the immediate release matrix are intended to relief the acute signs and symptoms showed in early stages of the migraine, the ketorolako contained in the extended-release pellets are intended to maintain the analgesic effect for 24 h.
MX2010003532A 2010-03-30 2010-03-30 Pharmaceutical combination with anti-migraine effect, in solid presentation of extended release. MX356601B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
MX2010003532A MX356601B (en) 2010-03-30 2010-03-30 Pharmaceutical combination with anti-migraine effect, in solid presentation of extended release.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MX2010003532A MX356601B (en) 2010-03-30 2010-03-30 Pharmaceutical combination with anti-migraine effect, in solid presentation of extended release.

Publications (2)

Publication Number Publication Date
MX2010003532A MX2010003532A (en) 2011-09-29
MX356601B true MX356601B (en) 2018-05-29

Family

ID=45492158

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2010003532A MX356601B (en) 2010-03-30 2010-03-30 Pharmaceutical combination with anti-migraine effect, in solid presentation of extended release.

Country Status (1)

Country Link
MX (1) MX356601B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW201422254A (en) * 2012-11-21 2014-06-16 Ferring Bv Composition for immediate and extended release

Also Published As

Publication number Publication date
MX2010003532A (en) 2011-09-29

Similar Documents

Publication Publication Date Title
AR115939A2 (en) COMPOSITION CONTAINING ULTRA-MICRONIZED PALMITOYL-ETHANOLAMIDE
CO6400186A2 (en) ULIPRISTAL ACETATE TABLETS
MX366175B (en) Concentrated therapeutic phospholipid compositions.
BR112012023021A2 (en) indazole compounds and their uses
UY30056A1 (en) MEPTAZINOL TRANSDERMAL ADMINISTRATION
CO6781465A2 (en) Pharmaceutical composition, treatment methods and uses thereof
BR112013000537A2 (en) bromhexine-containing aqueous composition
DOP2011000094A (en) PHARMACEUTICAL FORMULATION 514
NZ590291A (en) Pharmaceutical compositions for treatment of parkinson's disease
CR10402A (en) INHIBITORS OF 11-BETA-HYDROXIESTEROID DEHYDROGENASE 1
BR112017001192A2 (en) sugar compositions for tabletting by direct compression
AR087107A1 (en) INHIBITOR COMPOUND OF THE SIGNALING OF THE NOTCH TRAJECTORY
BR112015011430A2 (en) composition for immediate and prolonged release
BR112013005440A2 (en) "solidified sugar alcohol mixture".
ES2660019T3 (en) Patch containing diclofenac and thiocolchicose
BR112017001000A2 (en) sugar compositions for tabletting by direct compression
BR112013003064A2 (en) prophylactic or therapeutic agent for non-alcoholic steatohepatitis
MX2010003532A (en) Pharmaceutical combination with anti-migraine effect, in solid presentation of extended release.
ES2446494B1 (en) Therapeutic application of necrostatin-1 in steatohepatitis
AR084169A1 (en) COMBINATION THAT INCLUDES A FAMILY DERIVATIVE OF COMBRETASTATINAS AND CETUXIMAB
ATE534382T1 (en) PHARMACEUTICAL COMPOSITIONS OF ENTACAPONE MICRONIZED WITH SUGAR ALCOHOLS
CL2007002103A1 (en) USE OF PRAMIPEXOL AND AN ANALGESIC DERIVED FROM GAMMA AMINOBUTIRIC ACID TO TREAT THE PAIN; AND PHARMACEUTICAL COMPOSITION THAT UNDERSTANDS THEM.
ES2468665B1 (en) Pharmaceutical composition of chondroitin sulfate and celecoxib
EA200870554A1 (en) 5-GTP COMBINED THERAPY
TH114045S (en) Shoe soles

Legal Events

Date Code Title Description
FG Grant or registration